Literature DB >> 15660051

Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.

Shun Kohsaka1, Robert R Sciacca, Kenichi Sugioka, Ralph L Sacco, Shunichi Homma, Marco R Di Tullio.   

Abstract

BACKGROUND: Patients with left ventricular hypertrophy (LVH) have an increased risk of ischemic stroke. Although echocardiography is commonly used for the diagnosis of LVH, there is little information about the potential role of electrocardiography in providing additional prognostic information. The purpose of this study is to determine if electrocardiographically derived criteria for LVH provide additional prognostic value over echocardiography for predicting ischemic stroke in a multiethnic population.
METHODS: A population-based, case-control study was conducted in 177 patients who had had a first ischemic stroke and in 246 control patients matched for age, gender, and race or ethnicity. Left ventricular mass was measured by using 2-dimensional transthoracic echocardiography. Logistic regression analysis was performed to assess the risk of stroke associated with the presence of LVH diagnosed by electrocardiography (defined by 4 established criteria) after adjustment for the presence of other stroke risk factors and for echocardiographically determined LVH.
RESULTS: After adjustment for the presence of other established stroke risk factors, ECG-LVH was associated with ischemic stroke, using Sokolow-Lyon (odds ratio [OR] 2.12, 95% CI 1.05-4.30), Cornell voltage (OR 2.06, 95% CI, 1.26-3.35), and Cornell product criteria (OR 2.12, 95% CI, 1.13-3.97). Cornell voltage criterion (men, >2.8 mV; women, >2.0 mV) was associated with ischemic stroke even after adjustment for echocardiographically determined LVH (OR 1.73, 95% CI, 1.04-2.88). The combination of echo-LVH and a positive Cornell voltage criterion was associated with a 3.5-fold increase in stroke risk.
CONCLUSIONS: Our study indicates that the presence of ECG-LVH is associated with an increased risk of ischemic stroke after adjustment for other stroke risk factors. For Cornell voltage criteria, this relationship persisted even after adjustment for echocardiographic LVH. Electrocardiographic results can provide independent information for left ventricular myocardial changes and should be considered together with echocardiographic results to fully assess the risk of ischemic stroke.

Entities:  

Mesh:

Year:  2005        PMID: 15660051     DOI: 10.1016/j.ahj.2004.06.006

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

1.  A comparison of Cornell and Sokolow-Lyon electrocardiographic criteria for left ventricular hypertrophy in a military male population in Taiwan: the Cardiorespiratory fitness and HospItalization Events in armed Forces study.

Authors:  Fang-Ying Su; Yi-Hwei Li; Yen-Po Lin; Chung-Jen Lee; Chih-Hung Wang; Fan-Chun Meng; Yun-Shun Yu; Felicia Lin; Hsien-Tsai Wu; Gen-Min Lin
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

2.  Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.

Authors:  G Boner; M E Cooper; K McCarroll; B M Brenner; D de Zeeuw; P R Kowey; S Shahinfar; T Dickson; R S Crow; H-H Parving
Journal:  Diabetologia       Date:  2005-08-05       Impact factor: 10.122

3.  Electrocardiographic left atrial abnormalities and risk of ischemic stroke.

Authors:  Shun Kohsaka; Robert R Sciacca; Kenichi Sugioka; Ralph L Sacco; Shunichi Homma; Marco R Di Tullio
Journal:  Stroke       Date:  2005-10-06       Impact factor: 7.914

4.  Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the Rule Out Myocardial Infarction Using Computer Assisted Tomography trial.

Authors:  Quynh A Truong; Leon M Ptaszek; Elizabeth M Charipar; Carolyn Taylor; Joao D Fontes; Matthias Kriegel; Thomas Irlbeck; Michael Toepker; Christopher L Schlett; Fabian Bamberg; Ron Blankstein; Thomas J Brady; John T Nagurney; Udo Hoffmann
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

5.  Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study.

Authors:  Shun Kohsaka; Zhezhen Jin; Tatjana Rundek; Bernadette Boden-Albala; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

6.  Electromechanical relationship in hypertrophic cardiomyopathy.

Authors:  Xiaoping Lin; Hsin-Yueh Liang; Aurelio Pinheiro; Veronica Dimaano; Lars Sorensen; Miguel Aon; Larisa G Tereshchenko; Yihan Chen; Meixiang Xiang; Theodore P Abraham; M Roselle Abraham
Journal:  J Cardiovasc Transl Res       Date:  2013-06-15       Impact factor: 4.132

7.  Objective cardiac markers in dementia: results from the Kerala-Einstein study.

Authors:  S Buss; M L Noone; R Tsai; B Johnson; V G Pradeep; K A Salam; P S Mathuranath; J Verghese
Journal:  Int J Cardiol       Date:  2012-10-23       Impact factor: 4.164

8.  Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study.

Authors:  Sérgio Lamêgo Rodrigues; Lílian Cláudia Souza Angelo; Marcelo Perim Baldo; Eduardo Miranda Dantas; Alexandre Maulaz Barcelos; Alexandre C Pereira; José Eduardo Krieger; José Geraldo Mill
Journal:  Clin Res Cardiol       Date:  2013-05-10       Impact factor: 5.460

9.  Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility.

Authors:  Carlos Iribarren; Alfred D Round; Meng Lu; Peter M Okin; Edward J McNulty
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501

10.  Electrocardiographic criteria of left ventricular hypertrophy in general population.

Authors:  Edoardo Casiglia; Laura Schiavon; Valérie Tikhonoff; Anna Bascelli; Bortolo Martini; Alberto Mazza; Sandro Caffi; Daniele D'Este; Francesco Bagato; Monica Bolzon; Federica Guidotti; Hilda Haxhi Nasto; Mario Saugo; Francesco Guglielmi; Achille C Pessina
Journal:  Eur J Epidemiol       Date:  2008-03-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.